fashion -WSS

fashion

author：comprehensive 2025-10-01 07:41:24 - browse：9

What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a singular regulator?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We explain the debate over Vertex Pharmaceuticals’ novel pain drug, whose success in clinical trials comes with a sizable caveat. We also talk about the latest news in the life sciences, including an epitaph for Aduhelm and the retirement of an FDA icon.

For more on what we cover, here’s the news on Vertex; here’s more on Aduhelm; here’s the exit interview with Janet Woodcock; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： BioAge raises $170M for combination therapy with Zepbound

hotspot

WSS

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

There’s a way to spot data fakery. All journals should be using it

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Stanford president’s abrupt resignation sparks debate

There’s a way to spot data fakery. All journals should be using it

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

knowledge

fashion

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Dementia risk linked to living in disadvantaged areas: Study

New air purifier tech could be key to improving indoor air quality

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Medicare proposal to cover medical devices draws a mixed reaction

Scientists grapple with ethics of stem cell research

Medical leaders decry Supreme Court decision on affirmative action

The stock market has soared this year, but will it last? Experts weigh in

How one medical school became remarkably diverse

Key House Republican on health care plans exit from Congress

focus

'CMA Fest' 2023: How to watch, who is performing and more

Judge denies Trump's request for new trial in E. Jean Carroll case

Readout LOUD podcast: How biotech is using artificial intelligence

Biden report: The neurospychology of memory and aging

US jobless claims fall again as labor market continues to flash strength

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

hotspot

entertainment

hotspot

knowledge